准Pin1以克服MSS结直肠癌中的免疫抑制瘤微环境

Jian Wang1,2, Shuxin Tang3, Jinhua Fan4

  • 1Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing, China.

Frontiers in immunology
|November 17, 2025
PubMed
概括

Pin1通过创建免疫抑制瘤微环境 (TME) 来促进微卫星稳定性 (MSS) 和结直肠癌 (CRC). 抑制Pin1可以通过向NF-κB-CCL3-CCR5通路来克服MSSCRC中的免疫疗法耐药性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K